NeuroReAlign Therapy for Balance and Gait Rehabilitation in Stroke Survivors

Launched by MIDDLE EAST UNIVERSITY · Feb 24, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new treatment called NeuroReAlign Therapy to see if it can help improve balance and walking in people who have had a stroke and are more than six months into their recovery. The study will compare this new therapy to regular physiotherapy to find out which is more effective. It’s open to men and women aged 18 to 70 who have experienced either ischemic or hemorrhagic strokes, but those who have serious cognitive issues or cannot walk independently cannot participate.

Participants in the trial will receive either NeuroReAlign Therapy or conventional physiotherapy for four weeks. They will be assessed at the beginning of the study and again after four weeks to measure their balance and walking abilities through various tests. This research is important because understanding how effective NeuroReAlign Therapy is compared to traditional methods can help improve rehabilitation for stroke survivors in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with ischemic or hemorrhagic stroke
• • Have a stroke more than 6 months
• • Age between 18 and 70
• Exclusion Criteria:
• • Patients with severe cognitive impairments
• • Patients cannot walk independently